Newsroom archive

AAD 2023 Late-Breaking Phase III results PN
18 . 03 .2023
Press release
AAD 2023: Late-Breaking Phase III results demonstrate nemolizumab’s significant impact on prurigo nodularis
  • Global release
Scientific poster presentations
17 . 03 .2023
News story
AAD 2023: Extensive updates from Galderma’s broad and innovative portfolio through posters and presentation sessions
Cetaphil
15 . 03 .2023
Press release
Cetaphil Celebrates Global Initiative Highlighting Sensitive Skin with a Month of Skin Science Education
  • U.S. release
Performance FY 2022
13 . 03 .2023
Press release
Galderma delivers strong FY 2022 growth driven by innovation and commercial performance
  • Global release
02 . 03 .2023
Press release
Cetaphil® unveils digital AI skin analysis tool to empower and educate users with sensitive skin
  • U.S. release
Cetaphil
16 . 02 .2023
Press release
Cetaphil raises awareness of the connection between clothing and sensitive skin
  • U.S. release
Alastin_ReSurface
06 . 02 .2023
Press release
Galderma Launches Cutting-Edge Formulation With Alastin Skincare® Resurface Skin Polish Developed To Uncover Visibly Glowing Skin
  • U.S. release
Face By Galderma Before After
26 . 01 .2023
Press release
Galderma announces the launch of FACE by Galderma™ – a game-changing augmented reality solution helping healthcare professionals grow their activity and improve patient satisfaction
  • Global release
23 . 01 .2023
Press release
Galderma expands footprint with new Global Capability Center in Barcelona to support global growth
  • Global release
20 . 01 .2023
Press release
IMCAS 2023: Galderma to share latest data demonstrating high aesthetic improvement and patient satisfaction across its innovative portfolio
  • Global release